Medication info
Acleclair 200 mg Tablet (Acyclovir)

Acleclair 200 mg Tablet (Acyclovir)

Prescription medicationTabletIntravenous injection
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
You & Life Sciences Co., Ltd.
Appearance
Light blue round tablet
Packaging
100 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 201800308 · Approved 2018.01.23

Summary

Main use
Treatment and prevention of herpes simplex (including genital herpes), treatment of shingles, and treatment of chickenpox
Who receives it
Adults · Children
Adult administration
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. In cases of severe initial infection, treatment may be extended. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. 3) Treatment should be started as soon as possible after infection. In recurrent cases, it is preferable to start treatment when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be interrupted periodically every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose 5 times daily at approximately 4-hour intervals, excluding bedtime, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunocompromise or gastrointestinal malabsorption. 3) Treatment should be started as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience adverse reactions affecting the neuropsychiatric system; therefore, use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous injection. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer this drug at 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose twice daily at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per dose 3 times daily at approximately 8-hour intervals.
Child administration
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in patients with impaired immune function 2 years and older: Same as adults. Under 2 years: Administer 1/2 of the adult dose. There are currently no definitive data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears and, if possible, within 24 hours after the rash appears.

Ingredients

Manufacturer
You & Life Sciences Co., Ltd.

Efficacy & effects

Treatment and prevention of herpes simplex (including genital herpes), treatment of shingles, and treatment of chickenpox

  • Genital herpes
  • herpes simplex virus infection
  • herpes zoster virus infection
  • acute pain
  • chickenpox
View approved original text

This medication is primarily used to treat and prevent herpes simplex virus infections of the skin and mucous membranes, including primary and recurrent genital herpes. It is also effective in treating herpes zoster virus infections and is particularly helpful in alleviating acute pain. However, its efficacy in treating postherpetic neuralgia has not yet been clearly demonstrated. This medication is also used for the treatment of chickenpox in children over 2 years old. Overall, it is an effective drug for treating viral skin diseases.

How it is given

Adult administration

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. In cases of severe initial infection, treatment may be extended. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. 3) Treatment should be started as soon as possible after infection. In recurrent cases, it is preferable to start treatment when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be interrupted periodically every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose 5 times daily at approximately 4-hour intervals, excluding bedtime, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunocompromise or gastrointestinal malabsorption. 3) Treatment should be started as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience adverse reactions affecting the neuropsychiatric system; therefore, use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous injection. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer this drug at 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose twice daily at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per dose 3 times daily at approximately 8-hour intervals.

Child administration

○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in patients with impaired immune function 2 years and older: Same as adults. Under 2 years: Administer 1/2 of the adult dose. There are currently no definitive data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears and, if possible, within 24 hours after the rash appears.

Precautions

This medication should not be used in patients with a history of allergic reactions to this drug, its components, or valacyclovir. Additionally, since this medication contains lactose, it should not be taken by patients with genetic disorders that prevent lactose breakdown. Patients with poor kidney function should be cautious when using this medication, as neurological side effects can easily occur. Patients with impaired liver function should also use this medication carefully, as it may worsen liver function. Particular caution is required when administering this medication to children and elderly patients. Rarely, severe allergic reactions such as anaphylactic shock may occur while using this medication, so if symptoms like low blood pressure, difficulty breathing, or chest tightness occur, the medication should be stopped immediately and appropriate treatment should be sought. Skin reactions such as photosensitivity, rashes, or hives may occur, and if these symptoms appear, the medication should be stopped, and a doctor should be consulted. Severe skin conditions such as Stevens-Johnson syndrome or toxic epidermal necrolysis may manifest, so skin conditions should be closely monitored. This medication can affect mental status, causing various neuropsychiatric symptoms such as disturbances of consciousness, confusion, hallucinations, seizures, drowsiness, anxiety, etc., particularly more frequently in elderly patients or those with weak kidney function. There may also be effects on kidney function, resulting in symptoms like renal failure, hematuria, and proteinuria, so kidney status should be checked periodically. Blood-related side effects such as leukopenia, bleeding, and anemia may occur, so any abnormal symptoms should be reported immediately. Hepatic abnormalities such as hepatitis, jaundice, and elevated liver enzyme levels can occur, making liver function tests necessary. Gastrointestinal symptoms such as gastritis, vomiting, diarrhea, and abdominal pain may occur, and if these symptoms are severe, the medication should be stopped. It is important to maintain adequate hydration while using this medication to reduce the risk of dehydration and nephrotoxicity. To enhance therapeutic effectiveness, it is recommended to take the medication as soon as possible after the appearance of skin symptoms. When engaging in dangerous activities such as driving or operating machinery, caution should be taken due to potential disturbances in consciousness or drowsiness caused by side effects of this medication. Interactions may occur when used with other medications, especially those affecting the kidneys or in combination with certain drugs. Women who are pregnant or may become pregnant should carefully weigh the benefits and risks of this medication before use, and it is advisable not to take this medication while breastfeeding. This medication should be used with caution in children or newborns, especially when safety has not been established, and should only be used when absolutely necessary. Elderly patients may experience prolonged retention of the drug in the body due to reduced kidney function, so dosages and intervals should be adjusted, and adequate hydration is necessary. In case of overdose, serious side effects such as anxiety, coma, and seizures may occur, so medical consultation is essential, and treatment like dialysis may be necessary.

Side effects

  • Anaphylactic shock
  • anaphylactoid reaction
  • hypotension
  • dyspnea
  • chest tightness
  • photosensitivity reactions
  • fixed drug eruptions
  • rash
  • fever
  • vesicles
Show 121 more
  • urticaria-like erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • attention deficit
  • aggressive behavior
  • depersonalization
  • anxiety
  • ataxia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • seizures
  • drowsiness
  • tremors
  • agitation
  • amnesia
  • insomnia
  • anxiety
  • speaking to oneself
  • paresthesia
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • renal failure
  • crystalluria
  • elevated BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • bleeding
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • elevated AST
  • elevated ALT
  • elevated LDH
  • elevated ALP
  • elevated total bilirubin
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • soft stool
  • abdominal discomfort
  • stomach pain
  • abdominal pain
  • nausea
  • vomiting
  • indigestion
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • malaise
  • general fatigue
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • increased blood pressure
  • decreased blood pressure
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorders
  • hair loss
  • sweating
  • hyponatremia
  • low serum protein
  • elevated total cholesterol
  • elevated triglycerides
  • elevated serum potassium
  • low serum albumin
  • anxiety
  • coma
  • seizures
  • somnolence
  • confusion
  • hallucinations
  • agitation
  • epileptic seizures
  • coma state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is also advisable to keep it in a cool, dry place below 25 degrees Celsius.

Appearance and packaging

Appearance

Light blue round tablet

Package unit

100 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.